Mesenchymal Stem Cell Therapy (Stem Cells Arabia)

N/A

Report date: 2024/11/22 20:00:28

Base Information

Drug NameMesenchymal Stem Cell Therapy (Stem Cells Arabia)
Drug Alias NameWJ-MSCs
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJordan
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesStem Cells Arabia
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStem Cells Arabia
Active IndicationsN/A
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)

Other Information

ATC CodeN/A
Related LinksN/A